Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis

被引:53
|
作者
Andersson, M. L. E.
Petersson, I. F.
Karlsson, K. E.
Jonsson, E. N.
Mansson, B.
Heinegard, D.
Saxne, T.
机构
[1] Spenshults Hosp Rheumat Dis, Halmstad, Sweden
[2] Lund Univ, Dept Rheumatol, Lund, Sweden
[3] Lund Univ, Sect Cell & Matrix Biol, Dept Expt Med Sci, Lund, Sweden
[4] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden
关键词
D O I
10.1136/ard.2005.051292
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To monitor changes in serum concentrations of cartilage oligomeric matrix protein (COMP) during a 24-h period to determine any diurnal variation, and to estimate the half life of COMP in the circulation in patients with symptomatic knee osteoarthritis and in those with rheumatoid arthritis. Methods: Serum samples were drawn every 4 h (7 samples/patient over 24 h) in 10 patients with knee osteoarthritis and 14 patients with rheumatoid arthritis. Osteoarthritis was defined radiographically and clinically (American College of Rheumatology (ACR) criteria) and rheumatoid arthritis according to the 1987 ACR criteria. Serum COMP was measured by sandwich ELISA. A statistical model for the diurnal variation in the COMP levels was developed using the computer program NONMEM. Results: No considerable changes in COMP levels were observed during the day between 08:00 and 21:00 in either group. A significant decrease in serum COMP was apparent during bed rest at night, reaching the lowest levels between 04:00 and 05:00 (p < 0.03 or better v all other time points) in patients with osteoarthritis and in those with rheumatoid arthritis. From the rate of decreasing serum COMP levels, a putative half life of COMP in the circulation was estimated to be 7.4 h. Conclusion: During normal daytime activities, serum COMP levels are constant. The decrease during the night indicates a rapid elimination of COMP once it has reached the circulation. The stable COMP levels during the day suggest that it is not necessary to further standardise the time of serum sampling in clinical practice.
引用
收藏
页码:1490 / 1494
页数:5
相关论文
共 50 条
  • [21] Serum cartilage oligomeric matrix protein as a biomarker for predicting development and progression of knee osteoarthritis
    Akinmade, Akinola
    Oginni, Lawrence M.
    Adegbehingbe, Olayinka O.
    Okunlola, Abiodun I.
    Jeje, Olusola A.
    Adeyeye, Adeolu I.
    INTERNATIONAL ORTHOPAEDICS, 2021, 45 (03) : 551 - 557
  • [22] Serum cartilage oligomeric matrix protein as a biomarker for predicting development and progression of knee osteoarthritis
    Akinola Akinmade
    Lawrence M. Oginni
    Olayinka O. Adegbehingbe
    Abiodun I. Okunlola
    Olusola A. Jeje
    Adeolu I. Adeyeye
    International Orthopaedics, 2021, 45 : 551 - 557
  • [23] THE CORRELATION OF CARTILAGE OLIGOMERIC MATRIX PROTEIN WITH SONOGRAPHIC KNEE CARTILAGE THICKNESS AND DISEASE CHARACTERISTICS IN RHEUMATOID ARTHRITIS
    Rajalngham, S.
    Rajalingam, S.
    Hussein, H.
    Sridharan, R.
    Wahab, A. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1144 - 1145
  • [24] Cartilage oligomeric matrix protein as a potential biomarker for knee osteoarthritis
    Udomsinprasert, W.
    Mookkhan, N.
    Tabtimnark, T.
    Aramruang, T.
    Ungsudechachai, T.
    Saengsiwaritt, W.
    Jittikoon, J.
    Chaikledkaew, U.
    Honsawek, S.
    BONE & JOINT RESEARCH, 2024, 13 (06): : 261 - 271
  • [25] Cartilage Oligomeric Matrix Protein - inflammation biomarker in knee osteoarthritis
    Zivanovic, Sandra
    Rackov, Ljiljana Petrovic
    Zivanovic, Aleksandar
    Jevtic, Milorad
    Nikolic, Sandra
    Kocic, Sanja
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2011, 11 (01) : 27 - 32
  • [26] Serum levels of cartilage oligomeric matrix protein (COMP-TSP-5) in patients with rheumatoid arthritis stratified for functional class
    De Andrade, Fernanda Duarte
    Bender, Ana Ligia
    Da Silveira, Ines Guimaraes
    Stein, Helga
    Von Muhlen, Carlos Alberto
    Staub, Henrique Luiz
    SCIENTIA MEDICA, 2008, 18 (04) : 154 - 159
  • [27] Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
    Crnkic, M
    Månsson, B
    Larsson, L
    Geborek, P
    Heinegård, D
    Saxne, T
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 (04) : R181 - R185
  • [28] Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept
    Meliha Crnkic
    Bengt Månsson
    Lotta Larsson
    Pierre Geborek
    Dick Heinegård
    Tore Saxne
    Arthritis Res Ther, 5
  • [29] Functional capacity and cartilage oligomeric matrix protein (COMP) in the serum of patients with late onset rheumatoid arthritis
    Kolarz, G
    Hermann, J
    Krajnc, I
    Palkonyai, E
    Scherak, O
    Schödl, C
    Singer, F
    Temesvari, P
    Wagner, E
    Wottawa, A
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2002, 61 (04): : 435 - 439
  • [30] Serum levels of cartilage oligomeric matrix protein - A predicting factor and a valuable parameter for disease management in rheumatoid arthritis
    Skoumal, M
    Kolarz, G
    Klingler, A
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2003, 32 (03) : 156 - 161